Thus, an inevitable yet intriguing question to ask is whether or not this E2F5-TFDP1-BRG1-MYCN axis could differentiate signals that instigate physiological hepatocyte proliferation (i.e., liver regeneration) and those that stimulate pathological hepatocyte proliferation (i.e., liver cancer). This evidence concerns the gene MYCN and liver cancer.